Skip to main content
. 2016 Feb 15;8(2):246–269.

Table 5.

FDA-approved drugs as AD therapeutics

Drugs Mode of action AD symptoms
Donepezil AChE inhibitor Mild to severe AD
Memantine NMDAR antagonist Moderate to severe AD
Rivastigmine AChE and BuChE inhibitor Alzheimer-like pathology
Galantamine Cholinergic inhibitor Alzheimer-like pathology